Back to trial detailsIntake questionnaire
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
Applying to MD Anderson Cancer center · League City, Texas
Answer a few short questions to share with the research team.
0 of 3 answered